French biotech stock soars 30% after new data on experimental medicine
—·3h
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
ChannelsstocksCountriesusaCategoriespharma
Open original source ↗Published
6/30/2026, 8:43:45 AM
Fetched
6/30/2026, 9:08:07 AM
Confidence
60 / 100
Relevance
35 / 100
Trust
—
Language
en